Education
About Us
Working with TipRanks
Follow Us
Glenmark Life Sciences Limited (IN:GLS)
:GLS
| Dec 24 | Dec 22 | Dec 22 | Dec 21 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 22.83B | ₹ 21.61B | ₹ 21.23B | ₹ 18.85B | ₹ 15.37B |
| Gross Profit | ₹ 12.43B | ₹ 11.47B | ₹ 10.80B | ₹ 9.80B | ₹ 8.47B |
| Operating Income | ₹ 8.98B | ₹ 6.01B | ₹ 5.79B | ₹ 5.62B | ₹ 4.44B |
| EBITDA | ₹ 6.86B | ₹ 6.71B | ₹ 6.31B | ₹ 5.92B | ₹ 4.84B |
| Net Income | ₹ 4.71B | ₹ 4.67B | ₹ 4.19B | ₹ 3.52B | ₹ 3.13B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 3.01B | ₹ 3.80B | ₹ 5.17B | ₹ 1.40B | ₹ 307.68M |
| Total Assets | ₹ 28.50B | ₹ 27.02B | ₹ 24.71B | ₹ 19.97B | ₹ 17.26B |
| Total Debt | ₹ 171.48M | ₹ 193.57M | ₹ 28.84M | ₹ 9.33B | ₹ 210.00K |
| Net Debt | ₹ -2.84B | ₹ -2.64B | ₹ -5.09B | ₹ 8.17B | ₹ -99.77M |
| Total Liabilities | ₹ 5.18B | ₹ 5.64B | ₹ 4.17B | ₹ 12.44B | ₹ 13.24B |
| Stockholders' Equity | ₹ 23.32B | ₹ 21.38B | ₹ 20.54B | ₹ 7.53B | ₹ 4.02B |
| Cash Flow | |||||
| Free Cash Flow | ₹ 2.85B | ₹ 1.43B | ₹ 4.65B | ₹ 3.20B | ₹ 1.44B |
| Operating Cash Flow | ₹ 4.14B | ₹ 3.13B | ₹ 5.98B | ₹ 3.88B | ₹ 1.95B |
| Investing Cash Flow | ₹ -1.16B | ₹ -1.54B | ₹ -1.22B | ₹ -687.34M | ₹ -505.18M |
| Financing Cash Flow | ₹ -2.79B | ₹ -3.88B | ₹ -787.96M | ₹ -2.14B | ₹ -1.37B |